Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|01/23/12||8-K||Current report filing||63|
|12/27/11||8-K/A||Current report filing||115|
|12/23/11||CORRESP||A correspondence can be sent as a document with another submission type or can be sent as a separate submission.||16|
|11/18/11||8-K||Current report filing
|11/16/11||8-K||Current report filing||7|
|10/24/11||8-K||Current report filing||3|
|10/20/11||D||Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act||7|
|10/20/11||8-K||Current report filing